---
$id: https://graph.org.ai/products/commodity/51294505
$type: Product
source: UNSPSC
code: "51294505"
title: "Femoxetine"
class: "51294500"
classTitle: "Antidepressant piperidines"
family: "51290000"
familyTitle: "Antidepressants"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Femoxetine

**UNSPSC Code**: 51294505
**Class**: [Antidepressant piperidines](Antidepressant piperidines.mdx)
**Family**: [Antidepressants](../Antidepressants.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin agonist with the molecular formula C20H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8Y719ZLX8C, chemically known as piperidine, 3-((4-methoxyphenoxy)methyl)-1-methyl-4-phenyl-, (3r-trans)- but generally known as femoxetine, which bears US NIH Compound Identifier 43103. European Medicines Agency schedules Femoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07530MIG. The term FEMOXETINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). FEMOXETINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule femoxetine under HS 29333999 and SITC 51574. As of Q4 2014, FEMOXETINE remains the US FDA Preferred Term for this commodity. Femoxetine bears US NLM identifiers UMLS ID C0060145 and NCI Concept Code C80759. SMILES: O(CC1C(CCN(C1)C)c1ccccc1)c1ccc(OC)cc1.

